Hunan Hansen Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 521.895 million compared to CNY 621.173 million a year ago. Operating income was CNY 95.656 million compared to CNY 122.783 million a year ago. Net income was CNY 84.753 million compared to CNY 103.306 million a year ago. Basic earnings per share from continuing operations was CNY 0.1684 compared to CNY 0.2053 a year ago.